SUSMED,Inc. (TYO:4263)

SUSMED,Inc. Statistics

Total Valuation

SUSMED,Inc. has a market cap or net worth of JPY 17.07 billion. The enterprise value is 13.11 billion.

Market Cap	17.07B
Enterprise Value	13.11B

Important Dates

The next estimated earnings date is Friday, May 15, 2026.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

SUSMED,Inc. has 16.81 million shares outstanding. The number of shares has increased by 0.37% in one year.

Current Share Class	16.81M
Shares Outstanding	16.81M
Shares Change (YoY)	+0.37%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	42.80%
Owned by Institutions (%)	12.04%
Float	7.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	62.28
PB Ratio	4.15
P/TBV Ratio	4.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-27.02
EV / Sales	47.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 35.40

Current Ratio	35.40
Quick Ratio	34.83
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -11.25% and return on invested capital (ROIC) is -337.63%.

Return on Equity (ROE)	-11.25%
Return on Assets (ROA)	-7.01%
Return on Invested Capital (ROIC)	-337.63%
Return on Capital Employed (ROCE)	-12.12%
Weighted Average Cost of Capital (WACC)	11.24%
Revenue Per Employee	6.37M
Profits Per Employee	-11.28M
Employee Count	43
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

In the past 12 months, SUSMED,Inc. has paid 3.00 million in taxes.

Income Tax	3.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +64.24% in the last 52 weeks. The beta is 1.27, so SUSMED,Inc.'s price volatility has been higher than the market average.

Beta (5Y)	1.27
52-Week Price Change	+64.24%
50-Day Moving Average	984.60
200-Day Moving Average	913.53
Relative Strength Index (RSI)	57.62
Average Volume (20 Days)	277,290

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SUSMED,Inc. had revenue of JPY 274.00 million and -485.00 million in losses. Loss per share was -28.81.

Revenue	274.00M
Gross Profit	259.00M
Operating Income	-498.00M
Pretax Income	-482.00M
Net Income	-485.00M
EBITDA	-489.50M
EBIT	-498.00M
Loss Per Share	-28.81

Balance Sheet

The company has 3.96 billion in cash and n/a in debt, with a net cash position of 3.96 billion or 235.41 per share.

Cash & Cash Equivalents	3.96B
Total Debt	n/a
Net Cash	3.96B
Net Cash Per Share	235.41
Equity (Book Value)	4.11B
Book Value Per Share	243.63
Working Capital	3.92B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	8.50M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 94.53%, with operating and profit margins of -181.75% and -177.01%.

Gross Margin	94.53%
Operating Margin	-181.75%
Pretax Margin	-175.91%
Profit Margin	-177.01%
EBITDA Margin	-178.65%
EBIT Margin	-181.75%
FCF Margin	n/a

Dividends & Yields

SUSMED,Inc. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.37%
Shareholder Yield	-0.37%
Earnings Yield	-2.84%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SUSMED,Inc. has an Altman Z-Score of 71.19 and a Piotroski F-Score of 1.

Altman Z-Score	71.19
Piotroski F-Score	1